Frontiers in Pharmacology | Neuropharmacology

Original Research

Published on 08 Dec 2022

Gastrodin ameliorates the lipopolysaccharide-induced neuroinflammation in mice by downregulating miR-107-3p

in Neuropharmacology

Jin-Jin Song
Hui Li
Nan Wang
Xiao-Yan Zhou
Yan Liu
Zhen Zhang
Qian Feng
Yu-Ling Chen
Dan Liu
Jia Liang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1044375

4,502 views
16 citations

Original Research

Published on 06 Dec 2022

Discovery of pyrrole derivatives as acetylcholinesterase-sparing butyrylcholinesterase inhibitor

in Neuropharmacology

Shouyuan Sun
Tao Shi
Yan Peng
Honghua Zhang
Linsheng Zhuo
Xue Peng
Qien Li
Manxia Wang
Shuzhi Wang
Zhen Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1043397

2,511 views
3 citations

Mini Review

Published on 06 Dec 2022

Altered states, alkaloids, and catatonia: Monoaminoxidase inhibitors and their role in the history of psychopharmacology

in Neuropharmacology

Octavian Buda
Sorin Hostiuc
Ovidiu Popa-Velea
Steluta Boroghina

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1053534

2,625 views
1 citation

Original Research

Published on 06 Dec 2022

The efficacy and safety of epidural morphine/hydromorphone in the treatment of intractable postherpetic neuralgia: A single-center, double-blinded, randomized controlled, prospective, and non-inferiority study

in Neuropharmacology

Sun Yiping
Shen Jiayi
Hei Guang
Ji Yun
Ma Bingjie
Huang Xuehua
Yu Zhiyuan
Ma Pingchuan
Ma Ke

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1051357

2,576 views
4 citations

Editorial

Published on 01 Dec 2022

Editorial: Novel therapeutic approaches for the treatment of ocular disease, Volume II

in Neuropharmacology

Kyriaki Thermos
Stephanie C. Joachim

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1104105

928 views

Editorial

Published on 30 Nov 2022

Editorial: The pharmacotherapy of depression—searching for new mechanisms and drug interactions basic and clinical research

in Neuropharmacology

Katarzyna Stachowicz
Magdalena Sowa-Kućma
Anna Tabecka-Łonczyńska

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1098660

1,199 views

Mini Review

Published on 30 Nov 2022

Selective Vulnerability of the Locus Coeruleus Noradrenergic System and its Role in Modulation of Neuroinflammation, Cognition, and Neurodegeneration

in Neuropharmacology

Andrew K. Evans
Erwin Defensor
Mehrdad Shamloo

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1030609

5,604 views
13 citations

Review

Published on 29 Nov 2022

Noble gas and neuroprotection: From bench to bedside

in Neuropharmacology

Haiying Yin
Zijun Chen
Hailin Zhao
Han Huang
Wenwen Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1028688

6,108 views
20 citations

Review

Published on 28 Nov 2022

New developments and opportunities in drugs being trialed for amyotrophic lateral sclerosis from 2020 to 2022

in Neuropharmacology

JingSi Jiang
Yan Wang
Min Deng

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1054006

26,069 views
53 citations

Original Research

Published on 28 Nov 2022

Adolescent kratom exposure affects cognitive behaviours and brain metabolite profiles in Sprague-Dawley rats

in Neuropharmacology

Aiman Nadhirah Zul Aznal
Nurul Aqmar Mohamad Nor Hazalin
Zurina Hassan
Noorul Hamizah Mat
Nelson Jeng-Yeou Chear
Lay Kek Teh
Mohd Zaki Salleh
Farah Wahida Suhaimi

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1057423

6,886 views
9 citations

Original Research

Published on 24 Nov 2022

Bioinformatics analysis and in vivo validation of ferroptosis-related genes in ischemic stroke

in Neuropharmacology

Chang Liu
Zhixi Li
Hongjie Xi

Frontiers in Pharmacology

doi 10.3389/fphar.2022.940260

14,083 views
25 citations

Review

Published on 24 Nov 2022

Research progress in traditional Chinese medicine in the treatment of Alzheimer’s disease and related dementias

in Neuropharmacology

Wanying Tan
Lingjun Qi
Xiaoyu Hu
Zhenghuai Tan

Frontiers in Pharmacology

doi 10.3389/fphar.2022.921794

8,191 views
30 citations

Systematic Review

Published on 24 Nov 2022

Adverse event profiles of adjuvant treatment with opicapone in Parkinson’s disease: A systematic review and meta-analysis

in Neuropharmacology

Luwen Xie
Xiaoyi Qi
Xuan Wang
Bing He
Yu Wang
Wei Zhang
Zehui Yu
Mingming Deng
Sicheng Liang
Muhan Lü

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1042992

3,018 views
3 citations

Original Research

Published on 23 Nov 2022

AA147 ameliorates post-cardiac arrest cerebral ischemia/reperfusion injury through the co-regulation of the ATF6 and Nrf2 signaling pathways

in Neuropharmacology

Zhu Yuan
Liping Lu
Yingtao Lian
Yuanrui Zhao
Tingting Tang
Song Xu
Zhun Yao
Zhui Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1028002

4,192 views
22 citations

Original Research

Published on 23 Nov 2022

Doxycycline attenuates l-DOPA-induced dyskinesia through an anti-inflammatory effect in a hemiparkinsonian mouse model

in Neuropharmacology

Maurício dos Santos Pereira
Glauce Crivelaro do Nascimento
Mariza Bortolanza
Patrick Pierre Michel
Rita Raisman-Vozari
Elaine Del Bel

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1045465

3,890 views
14 citations

Original Research

Published on 23 Nov 2022

The differential in vivo contribution of spinal α2A- and α2C-adrenoceptors in tonic and acute evoked nociception in the rat

in Neuropharmacology

Gustavo López-Córdoba
Guadalupe Martínez-Lorenzana
Jair Lozano-Cuenca
Miguel Condés-Lara
Abimael González-Hernández

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1023611

7,685 views
2 citations